Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Esomeprazole 20 mg for frequent heartburn
NCT01370538Phase 3Completed
- Sponsor
- AstraZeneca
- Start
- Aug 2011
- Primary completion
- Oct 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of esomeprazole in gastroesophageal reflux disease (GERD), sponsored by AstraZeneca. Started Aug 2011; status: completed.
02
Drugs
esomeprazole
03
Conditions
gastroesophageal reflux disease (GERD)
Beyond the preview
Go deeper on NCT01370538.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01370538.